ONE DIAGNOSIS, MANY ARCHITECTURES: GENOMIC DISSECTION OF DEPRESSION HETEROGENEITY

Overall Abstract Depression is among the most genetically tractable psychiatric disorders, yet its clinical and aetiological heterogeneity remains poorly resolved. This symposium brings together four programmes of work that address depression's heterogeneity from complementary genetic angles: phenotypic subtyping, seasonal variation, psychotic features, and diagnostic precision. Mitchell (QIMR) will examine polygenic prediction of seasonal affective disorder and the influence of seasonality on depression (N=12,613), demonstrating significant associations between SAD and latitude, and a protective chronotype-by-latitude interaction whereby morning chronotype buffers the risk-increasing effect of higher latitude. Polygenic scores for MDD, bipolar disorder, anxiety, vitamin D, and educational attainment are associated with seasonality symptom burden. McGrath (Cambridge) presents the first GWAS meta-analysis of psychotic depression, combining health-record, prescription-based, and self-report definitions across European and African ancestries (> 13,500 cases), testing whether clinical heterogeneity in depression reflects underlying biological heterogeneity. Harder (Karolinska Institutet) reports the largest genetic analysis of neurovegetative MDD subtypes, contrasting AERS+ (hyperphagia/hypersomnia; Neff=47,858) with AERS− (weight loss/insomnia; Neff=156,624). The subtypes are only moderately correlated (rg=0.64) and show sharply divergent metabolic genetic profiles, with subtype differences persisting after BMI conditioning. Merola (KCL) presents a GWAS meta-analysis of DSM-defined depression (106,183 cases, 298,357 controls) using an identical depression phenotype (IDP). Observation that ADHD genetic correlations diverge sharply between broad and DSM-defined depression motivated GWAS by subtraction across seven variant MDD phenotypes, isolating novel loci that more specific to MDD and implicating different biological pathways compare to broader MDD definitions. The IDP-derived PGS also shows superior cross-ancestry prediction in African and South Asian samples compared with larger but less precise GWAS. Together, these studies demonstrate that resolving depression's heterogeneity yields distinct and more interpretable genetic architectures.

Authors

Institutions

Publication Details

Journal
European Neuropsychopharmacology
Published
2026-09-21
DOI
https://doi.org/10.1016/j.euroneuro.2026.112981
Primary Topic
Genetic Associations and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

ONE DIAGNOSIS, MANY ARCHITECTURES: GENOMIC DISSECTION OF DEPRESSION HETEROGENEITY

Solomon Teferra, Gerome Breen, Lu Yi
European Neuropsychopharmacology
Genetic Associations and Epidemiology
article

ONE DIAGNOSIS, MANY ARCHITECTURES: GENOMIC DISSECTION OF DEPRESSION HETEROGENEITY

Solomon Teferra, Gerome Breen, Lu Yi
article en

Abstract

Overall Abstract Depression is among the most genetically tractable psychiatric disorders, yet its clinical and aetiological heterogeneity remains poorly resolved. This symposium brings together four programmes of work that address depression's heterogeneity from complementary genetic angles: phenotypic subtyping, seasonal variation, psychotic features, and diagnostic precision. Mitchell (QIMR) will examine polygenic prediction of seasonal affective disorder and the influence of seasonality on depression (N=12,613), demonstrating significant associations between SAD and latitude, and a protective chronotype-by-latitude interaction whereby morning chronotype buffers the risk-increasing effect of higher latitude. Polygenic scores for MDD, bipolar disorder, anxiety, vitamin D, and educational attainment are associated with seasonality symptom burden. McGrath (Cambridge) presents the first GWAS meta-analysis of psychotic depression, combining health-record, prescription-based, and self-report definitions across European and African ancestries (> 13,500 cases), testing whether clinical heterogeneity in depression reflects underlying biological heterogeneity. Harder (Karolinska Institutet) reports the largest genetic analysis of neurovegetative MDD subtypes, contrasting AERS+ (hyperphagia/hypersomnia; Neff=47,858) with AERS− (weight loss/insomnia; Neff=156,624). The subtypes are only moderately correlated (rg=0.64) and show sharply divergent metabolic genetic profiles, with subtype differences persisting after BMI conditioning. Merola (KCL) presents a GWAS meta-analysis of DSM-defined depression (106,183 cases, 298,357 controls) using an identical depression phenotype (IDP). Observation that ADHD genetic correlations diverge sharply between broad and DSM-defined depression motivated GWAS by subtraction across seven variant MDD phenotypes, isolating novel loci that more specific to MDD and implicating different biological pathways compare to broader MDD definitions. The IDP-derived PGS also shows superior cross-ancestry prediction in African and South Asian samples compared with larger but less precise GWAS. Together, these studies demonstrate that resolving depression's heterogeneity yields distinct and more interpretable genetic architectures.

European NeuropsychopharmacologyVol. 111
King's College London (GB), Karolinska Institutet (SE), Addis Ababa University (ET)
Good health and well-being
Openalex Percentile: Top 11%
Genetic Associations and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.